ecancer

Reducing the risk of contracting COVID-19 in patients with NSCLC (DE)

Dr Giuseppe Giaccone, Dr Neal Navani, Professor Eric Lim

2 Mar 2021

Reducing the risk of contracting COVID-19 in patients with NSCLC (IT)

Dr Giuseppe Giaccone, Dr Neal Navani, Professor Eric Lim

2 Mar 2021

Reducing the risk of contracting COVID-19 in patients with NSCLC (ES)

Dr Giuseppe Giaccone, Dr Neal Navani, Professor Eric Lim

2 Mar 2021

ITACA NSCLC study: Final results

Prof Silvia Novello - University of Turin, Turin, Italy

16 Feb 2021

KEYNOTE-598: pembrolizumab with ipilimumab or placebo in patients with untreated metastatic NSCLC

Prof Michael Boyer - Chris O’Brien Lifehouse, Sydney, Australia

16 Feb 2021

OncoAlert and ecancer weekly roundup for February 07 - 13, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

15 Feb 2021

OncoAlert and ecancer weekly roundup for February 01 - 06, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

9 Feb 2021

Latest in EGFR-positive NSCLC with exon 20 insertion mutations

Prof Sanjay Popat, Prof Michael Thomas, Dr Marina Garassino, Dr Rosario Campelo, Dr Enriqueta Felip

9 Feb 2021

WCLC 2020 overview

Dr Luis Raez - Memorial Healthcare System, Hollywood, FL, USA

5 Feb 2021

OncoAlert and ecancer weekly roundup for January 25 - 31, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

4 Feb 2021

WCLC 2020: Updates from the CHRYSALIS trial and what it means for patients with NSCLC

Dr Joshua Bauml and Dr Joshua Sabari

3 Feb 2021

New data from rare EGFR alterations in NSCLC from WCLC 2020

Prof Tony Mok - Chinese University of Hong Kong, Shatin, Hong Kong

2 Feb 2021

More from ecancer